Meropenem Sandoz (Meropenem Trihydrate)

Meropenem, the active ingredient in Meropenem Sandoz, is a carbapenem antibiotic presented as an intravenous solution for intravenous use. It is employed to treat serious bacterial infections such as intra‑abdominal sepsis, hospital‑acquired pneumonia, urinary tract infections, septicemia and meningitis in adult patients.

GNH USA supplies Meropenem Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for severe bacterial infections that require intravenous therapy.

- Complicated intra‑abdominal infections: achieves bacterial eradication in severe abdominal sepsis. - Complicated urinary tract infections: provides effective coverage against resistant uropathogens. - Nosocomial pneumonia: treats hospital‑acquired lung infections caused by Gram‑negative and Gram‑positive bacteria. - Septicemia: rapidly clears bloodstream infections with multidrug‑resistant organisms. - Meningitis: penetrates the cerebrospinal fluid to eradicate bacterial meningitis pathogens.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Diarrhea: mild to moderate loose stools. - Nausea: occasional feeling of queasiness. - Rash: transient skin erythema. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: especially in patients with renal impairment or high doses. - Clostridioides difficile colitis: severe intestinal inflammation caused by bacterial overgrowth.

Use meropenem only under medical supervision and adjust dosing for renal function.

- Renal impairment: dose reduction may be required based on creatinine clearance. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Seizure risk: monitor patients with central nervous system disorders. - Pregnancy and lactation: assess risk‑benefit ratio before use. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines that affect renal clearance or seizure threshold.

Major Interactions (Avoid): - Valproic acid: may reduce antiepileptic effect, increasing seizure risk. - Aminoglycosides: combined nephrotoxicity potential; monitor kidney function closely.

Moderate Interactions (Monitor Closely): - Loop diuretics: may enhance nephrotoxic effects; assess renal parameters. - Probenecid: can decrease renal excretion of meropenem, raising plasma levels. - Oral contraceptives: theoretical reduction in efficacy; advise additional contraceptive measures.